Immune checkpoint inhibitors for patients with colorectal cancer: mismatch repair deficiency and per...
Immune checkpoint inhibitors for patients with colorectal cancer: mismatch repair deficiency and perspectives
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Harnessing the immune system to fight tumor cells is becoming a promising and innovative therapeutic strategy for a large spectrum of malignancies. The evaluation of immunotherapy in the context of colorectal cancers (CRCs) has brought to light mismatch repair deficiency as a major predictive biomarker for the efficacy of immune checkpoint blockade...
Alternative Titles
Full title
Immune checkpoint inhibitors for patients with colorectal cancer: mismatch repair deficiency and perspectives
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2216516728
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2216516728
Other Identifiers
ISSN
1758-194X
E-ISSN
1758-1958
DOI
10.2217/crc-2017-0004